ALBERT DAVID
Back to Income Statement
|
ALBERT DAVID Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹346 Cr | ₹362 Cr | ₹342 Cr | ₹314 Cr | ₹247 Cr |
What is the latest Revenue of ALBERT DAVID ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹346 Cr |
| Mar2024 | ₹362 Cr |
| Mar2023 | ₹342 Cr |
| Mar2022 | ₹314 Cr |
| Mar2021 | ₹247 Cr |
How is Revenue of ALBERT DAVID Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹346 Cr | -4.61 | |
| Mar2024 | ₹362 Cr | 6.12 | |
| Mar2023 | ₹342 Cr | 8.95 | |
| Mar2022 | ₹314 Cr | 26.70 | |
| Mar2021 | ₹247 Cr | - | |
Compare Revenue of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹346.4 Cr | -8% | -14.5% | -23.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -8% |
-14.5% |
-23.4% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses